// App-Quantinova.ai

581 : Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA Appropriateness Method (RAM)

Researchers

Presenter

  • Giorgia Saccullo

Principal Investigators

  • Marco Marietta

  • Monica Carpenedo

  • Valerio De Stefano

  • Anna Falanga

  • Augusto B. Federici

  • Francesco Rodeghiero

  • Alberto Tosetto

  • Sergio Siragusa

Medical Centers

  • Institute of Hematology, Catholic University, Rome, Italy

  • Hematology Department, San Bortolo Hospital,Vicenza, Italy

  • Hematology and Clinical Research Unit, San Gerardo Hospital, Monza, Italy

  • Hematology Unit, Thrombosis and Hemostasis Reference Regional Center, University of Palermo, Palermo, Italy

  • Department of Clinical Sciences & Community Health, Hematology & Blood Transfusion L.SACCO University Hospital, Milano, Italy

  • Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy

  • Division of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy

  • Centro Emofilia, Policlinico Universitario di Modena, Italy, modena, Italy

  • GIMEMA Italian Myeloma Network, Varese, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Thrombocytopenia

  • Solid malignancies

Biomarkers

  • N-Acylethanolamine acid amidase

Drug/Treatment

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved